Axogen, Inc. (AXGN)
Sector: Healthcare
Industry: Electromedical & Electrotherapeutic Apparatus
Country: United States
Exchange: NASDAQ
Market cap: $2.60B
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
Latest financial period: June 30, 2026
Filed with the SEC: July 29, 2026
Estimated earnings date: November 4, 2026
Profit #1293 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROE/ROA | 10.3% | 10.3% | 12.1% | 16.5% |
Growth #133 of 1484 companies
Payout #1117 of 1484 companies
Safety #625 of 1484 companies
Price #1338 of 1484 companies
